Unknown NA INTERVENTIONAL 1-arm NCT01367054

Adverse Events in Pharmaceutical Bioequivalence Study of Two Formulations of Metformine Hydrochloride 500 mg

Sponsor: Biocinese

Conditions Nutritional and Metabolic Diseases

Updated 5 times since 2017 Last updated: Jun 3, 2011 Started: Jun 30, 2008 Primary completion: Jul 31, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01367054, this NA trial focuses on Nutritional and Metabolic Diseases and remains ongoing. Sponsored by Biocinese, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biocinese

Data source: Biocinese

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toledo, Brazil